Dual disorder: does expert clinical experience support the rationale for cariprazine use?

In conclusion, the panel recommends that individuals with DD should be cared for in a single center. Pharmacologic treatment in individuals with DD needing both control of symptoms related to schizophrenia spectrum disorders and substance withdrawal should ideally be based on using a non-sedative antipsychotic with anti-craving activity.PMID:38497891 | DOI:10.26355/eurrev_202403_35622

Source: Pharmacological Reviews - March 18, 2024 Category: Drugs & Pharmacology Authors: J Martinez-Raga M Bajouco D Kenzin J Sahlsten D De Berardis G Tzeferakos E Wagner G Fran ça J Johnsen C Roncero H Grunze Source Type: research